Bausch Historical Cash Flow
| BHC Stock | CAD 11.42 0.20 1.72% |
Analysis of Bausch Health cash flow over time is an excellent tool to project Bausch Health Companies future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Free Cash Flow of 564.9 M or Begin Period Cash Flow of 569.7 M as it is a great indicator of Bausch Health ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Bausch Health Companies latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bausch Health Companies is a good buy for the upcoming year.
Bausch |
About Bausch Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Bausch balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Bausch's non-liquid assets can be easily converted into cash.
Bausch Health Cash Flow Chart
Add Fundamental
Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Capital Expenditures
Capital Expenditures are funds used by Bausch Health Companies to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Bausch Health operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Bausch Health's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Bausch Health Companies current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Bausch Health's Change In Cash is very stable compared to the past year. As of the 2nd of January 2025, Other Non Cash Items is likely to grow to about 939.4 M, while Sale Purchase Of Stock is likely to drop (29 M).
| 2024 | 2025 (projected) | Capital Expenditures | 312.8M | 170.5M | Dividends Paid | 409.7M | 430.2M |
Bausch Health cash flow statement Correlations
Click cells to compare fundamentals
Bausch Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bausch Health cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Sale Purchase Of Stock | (30M) | (52M) | (31M) | (24M) | (27.6M) | (29.0M) | |
| Change To Inventory | (77M) | (16M) | (198M) | (322M) | (289.8M) | (275.3M) | |
| Change In Cash | (1.4B) | 303M | (1.5B) | 371M | 333.9M | 350.6M | |
| Free Cash Flow | 802M | 1.1B | (996M) | 760M | 874M | 564.9M | |
| Change In Working Capital | (366M) | (128M) | (396M) | (582M) | (523.8M) | (497.6M) | |
| Begin Period Cash Flow | 3.2B | 1.8B | 2.1B | 591M | 679.7M | 569.7M | |
| Other Cashflows From Financing Activities | (77M) | (121M) | (139M) | (82M) | (73.8M) | (77.5M) | |
| Depreciation | 1.8B | 1.6B | 1.4B | 1.3B | 1.5B | 926.8M | |
| Other Non Cash Items | 581M | 1.0B | (1.5B) | 778M | 894.7M | 939.4M | |
| Capital Expenditures | 309M | 283M | 268M | 272M | 312.8M | 170.5M | |
| Total Cash From Operating Activities | 1.1B | 1.4B | (728M) | 1.0B | 1.2B | 735.4M | |
| Net Income | (559M) | (937M) | (212M) | (611M) | (549.9M) | (522.4M) | |
| Total Cash From Financing Activities | (2.3B) | (1.5B) | (474M) | 1.5B | 1.7B | 1.8B | |
| End Period Cash Flow | 1.8B | 2.1B | 591M | 962M | 1.1B | 603.9M | |
| Stock Based Compensation | 105M | 128M | 126M | 132M | 151.8M | 107.0M | |
| Change To Account Receivables | 170M | (229M) | (57M) | (195M) | (224.3M) | (213.0M) | |
| Investments | (261M) | (4M) | (303M) | (2.1B) | (1.9B) | (1.8B) | |
| Net Borrowings | 1.6B | (2.2B) | (1.3B) | (1.0B) | (909M) | (863.6M) | |
| Total Cashflows From Investing Activities | (419M) | (261M) | 409M | (303M) | (348.5M) | (365.9M) | |
| Change To Operating Activities | 1M | 12M | (4M) | (66M) | (59.4M) | (56.4M) | |
| Change To Netincome | 1.5B | 151M | 895M | (1.6B) | (1.4B) | (1.4B) | |
| Change To Liabilities | (149M) | (471M) | 121M | (75M) | (67.5M) | (64.1M) |
Pair Trading with Bausch Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bausch Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Health will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Bausch Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bausch Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bausch Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bausch Health Companies to buy it.
The correlation of Bausch Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bausch Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bausch Health Companies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bausch Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.